Form 4 for OKUR OnKure Therapeutics, Inc.
Accepted 2021-08-26 00:00:00 ET · period of report 2021-08-25 · accession 0001209191-21-053520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-26 | 2021-08-25 | OKUR | Cruse Michael | Senior VP-Corp. Ops | P - Purchase | $7.45 | +2,500 | 2,500 | New | +$18.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | P | A | 2,500 | $7.45 | 2,500 | D | — | — | (F1) The weighted average purchase price for the transaction was $7.4464. The shares were purchased at a range of prices between $7.425 and $7.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |